Summary. The efficacy of a hypoglycaemic plant extract, in common use by Kuwaiti diabetic individuals, was evaluated using both streptozotocin-induced diabetic and normal rats. A significant decrease in blood glucose concentration was demonstrated on glucose tolerance tests, as compared to untreated animals. The sum of the fasting, 1 and 2 h blood glucose values, decreased from 18.5+0.72 to 13.6+0.62mmol/1 (p < 0.001) and from 58.6+2.83 to 44.5 + 3.12 mmol/1 (p <0.005) in normal and diabetic animals treated for 1 week, respectively. Treatment with the extract was not found to significantly alter insulin levels or intestinal glucose absorption. The mode of action of the hypoglycaemic preparation remains to be elucidated.
The pathogenesis of diabetes mellitus and the possibility of its management by the oral administration of hypoglycaemic agents have stimulated great interest in recent years. To date only two groups of oral hypoglycaemic agents are available for clinical use, sulphonylureas and biguanides. In accordance with the recommendation of the WHO expert committee on diabetes mellitus [1] an investigation of hypoglycaemic agents of plant origin used in traditional medicine seems important. We report on a biossay model to investigate the hypoglycaemic action achieved with a plant extract in use by Kuwaiti diabetic individuals.
Materials and methods

Animals
Diabetes was induced in male Wistar albino rats (200-250 g) by the intraperitoneal administration of streptozotocin (60mg/kg body weight dissolved in 0.0t tool/1 citrate buffer, pH 4.5, immediately before use). Subsequently, rats received a daily subcutaneous dose of 2 IU protamine zinc insulin for 7 days before they were subjected to the experiments. Diabetes was confirmed by testing for glucosuria, using glucose indicator sticks (Rapignost, Hoechst, FRG), and for hyperglycaemia by the oral glucose tolerance test. All animals were allowed free access to tap water and laboratory chow (E. Dixon & Sons Ware Ltd., Ware, England).
Preparation of the plant extract and treatment of animals
A powdered mixture (5 g) of equal portions of Nigella sativa, Myrrh, Gum arabic, Gum asafoetida and Aloe was boiled in 100 ml distilled water for 10 min. Diabetic and normal animals were given a daily oral dose of 10ml/kg body weight, by gastric intubation, for a period of t week. The dose was empirically based on that used by local diabetic subjects.
The oral glucose tolerance test and insulin measurements
Following the treatment period both normal and diabetic rats, together with untreated control animals, were fasted overnight. They were then anaesthetised with phenobarbitone sodium (50mg/kg body weight, intra peritoneally) and maintained at 37 ~ in a multi-chambered thermostated restraining cage. Glucose (3 g/kg body weight) was administered by gastric intubation and blood samples collected at 15, 30, 60, 90 and 120 min from the tail vein for glucose and insulin estimations. Glucose was measured in 0.02 ml of whole blood using glucose oxidase kits (Boehringer Mannheim, GmbH, Mannheim, FRG) and a UV 25 spectrophotometer (Beckman, Geneva, Switzerland). Serum insulin was measured by a double antibody radioimmunoassay technique using Phadebas insulin kits (Pharmacia Diagnostics, Uppsala, Sweden) and a gamma counter (LKB Wallac 1282 Compugamma, Turku, Finland). Standards for the assay were prepared from human insulin as supplied with the kit. The insulin antibody supplied with Phadebas kit showed 100% cross reactivity with rat insulin (M. S. Khatim, personal communication). All animals were free of circulating insulin binding antibodies.
Glucose absorption by a rat gut preparation in-situ
The method of Swintosky and Pogonowskawala [2] was adopted to study glucose absorption. Glucose 10 mmol/1) in Krebs-Ringer bicarbonate buffer, KRB) was administered into a 40-cm intestinal segment starting from the pyloric sphincter. Aliquots (0.2 ml) of the intestinal contents were withdrawn at 10-min intervals for 70 min and analyzed for glucose. The rate of glucose absorption was calculated from the slope of the straight line obained by plotting the logarithm of the residual glucose concentration (mmol/1) versus time (min). Validation of the technique was confirmed by co-administering phenol red a The equivalent of 10 ml/kg body weight of the hypoglycaemic plant extract. Values are expressed as mean + SEM of the slope of the curves representing rates of absorption. Differences between untreated and treated animals was statistically non-significant (0.1 mmol/l KRB) with the glucose load to ascertain steady state conditions. Phenol red concentrations were estimated spectrophotometrically at 540 nm. Furthermore the effect of Ouabain (0.34 mmol/1 in KRB) a known inhibitor of glucose absorption, was also tested in a similar manner [3] .
Effect of the plant extract on body weight
Body weights of diabetic and normal rats were recorded daily during the period of treatment with the extract. The weights of corresponding control groups of rats were simultaneously recorded.
Statistical calculations
Data were expressed as the mean • SEM for all experiments, and probabilities (p) of chance difference between groups were calculated according to Student's two tailed t-test. Where relevant, slopes were calculated from linear regression curves.
Results
Effect of the hypoglycaemic extract on the oral glucose tolerance test
Treatment of both normal and diabetic animals with the crude extract produced a significant decrease in blood glucose concentrations as compared to control animals ( Fig. 1) . The sum of fasting, 1 and 2 h blood glucose values, which is an index of glucose tolerance [4] , was reduced from 18.5 +0.7 to 13.6+0.6mmol/1 (p <0.001) and from 58.6 _+ 2.8 to 44.5 + 3.1 mmol/1 (p < 0.005) following 1 week administration of the extract to normal and diabetic rats, respectively.
Effect of the hypoglycaemic extract on the intestinal absorption of glucose
Phenol red absorbance values at 540 nm were 0.380_+ 0.005 and 0.514 + 0.007 (n = 4) at the beginning and end of the experiment respectively. This confirms the prevalence of steady state conditions. Further validation of the method was obtained by demonstrating the inhibitory effect of ouabain on glucose absorption which de- 
Values are expressed as mean + SEM. Differences between untreated and treated animals were statistically non-significant. Numbers of animals studied are given in parentheses creased the rate from 7.7+0.9 (n=8) to 3.7+ 0.50 nmol/min/40 cm gut (n = 3) (p < 0.005). Treatment with the plant extract had no effect on glucose absorption except when it was administered concomittantly with the glucose load (p<0.05) ( Table 1) .
Effect of the hypoglycaemic extract on body weight and serum insulin levels
No significant change in body weight was observed in treated diabetic and normal animals as compared to their controls. The extract had no effect on serum insulin levels during the glucose tolerance test (Table 2) .
Discussion
A plant extract, in use by a number of Kuwaiti diabetics, was shown to possess a significant hypoglycaemic effect in both normal and streptozotocin-diabetic rats.
A mild diarrhoea developed in some rats during the first three days of treatment, but did not result in dehydration evident from lack of change in body weight.
The extract did not significantly impair the intestinal absorption of glucose unless administered simultaneously with the glucose load in vitro. It had no direct stimulatory effect on insulin secretion since no enhancement of circulating insulin levels occured in treated animals.
The mechanism by which hypoglycaemia is induced by the extract needs to be further investigated.
